We and others recently proposed that the protein phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 (P-Rex1) is a potential breast cancer biomarker to predict sensitivity to therapeutic inhibitors of phosphatidylinositol 3-kinase (PI3K) [5, 6]. Here, PREX1 is linked to breast cancer.